All times shown are PDT (GMT-7) (San Francisco)

Displaying One Session

Satellite Channel 2

Non-Commercial Satellite
Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Date
Thu, Jul 9, 2020
Time
06:00 AM - 07:00 AM
Session Description
Tuberculosis is the leading cause of mortality among persons living with HIV (PLHIV), accounting for a third of AIDS-related deaths in 2019. While estimates suggest that PLHIV are 19 times more likely to contract TB, case-finding among PLHIV remains low with 49% unaware of their coinfection. WHO-recommended LF-LAM facilitates quicker TB diagnosis and initiation on treatment (or TB preventive therapy for those without active TB) among PLHIV, but uptake of this test in high TB/HIV burden countries has been too slow. In this session, we will explore barriers to TB diagnosis among PLHIV, spotlight successful adoptions of LF-LAM, highlight results from existing LF-LAM, and preview other diagnostic tools in the pipeline. The session will also include a panel discussion outlining what needs to be done to accelerate access to appropriate tests and treatments to reduce TB-related deaths among PLHIV.
Non-Commercial Satellite

Full Session Recording

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

The challenge: Screening people living with HIV for TB

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Overview of updates to global LF-LAM guidance

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Scaling LF-LAM: The Kenya experience

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Scaling LF-LAM in Zambia

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

New LF-LAM technology in the pipeline

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Results from FujiLAM

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

LF-LAM technology and testing on the horizon: Panel and panelist introduction

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Tools for LF-LAM in development

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

TB co-infection and testing: A personal experience

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Conclusion and call to action: Commitment for scaling LF-LAM

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2